Journal of Neurology

, Volume 259, Issue 10, pp 2019–2030 | Cite as

Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management

Review

Abstract

Mortality related to herpes simplex virus encephalitis (HSE) dropped dramatically with the systematic initiation of antiviral treatment in encephalitic syndromes. Further efforts need to be taken to reduce long-term morbidity in the survivors. In this regard, the high rate of postencephalitic epilepsy, which is frequently refractory to medical treatment, contributes significantly to the unfavorable clinical outcome of the disease. Seizures during the acute phase of HSE are the main risk for the development of postencephalitic epilepsy. Yet, there are no randomized controlled trials for the management of acute seizures, preventive measures or the ideal duration of antiepileptic treatment. Hence, concepts for the medical treatment of seizures during the acute phase of HSE and postencephalitic epilepsy are eagerly awaited. Epilepsy surgery is a potential treatment option for the latter, but only promising in a subgroup of patients suffering from unilateral mesio-temporal lobe epilepsy and congruent neuropsychological impairment. Relapsing HSE and post-infectious autoimmune conditions can lead to seizures in the aftermath of acute HSE. These conditions need to be kept in mind in order to promptly assure the initiation of accurate diagnostic steps and respective treatment. The purpose of this review is to summarize the current pathogenetical understanding, clinical and diagnostic considerations, and treatment options of seizures in acute HSE and postencephalitic epilepsy.

Keywords

Herpes encephalitis Seizures Epilepsy Intractable Surgery 

References

  1. 1.
    Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT (1988) The risk of unprovoked seizures after encephalitis and meningitis. Neurology 38:1407–1410PubMedCrossRefGoogle Scholar
  2. 2.
    Aravalli RN, Hu S, Rowen TN, Palmquist JM, Lokensgard JR (2005) Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 175:4189–4193PubMedGoogle Scholar
  3. 3.
    Aurelius E, Andersson B, Forsgren M, Skoldenberg B, Strannegard O (1994) Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis. J Infect Dis 170:678–681PubMedCrossRefGoogle Scholar
  4. 4.
    Baek MY, Kim YM, Lee YJ, Nam SO (2010) Risk factors for epilepsy after central nervous system infection in children. Korean Child Neurol Soc 18:33–39Google Scholar
  5. 5.
    Baringer JR (2008) Herpes simplex infections of the nervous system. Neurol Clin 26:657–674, viiiGoogle Scholar
  6. 6.
    Baringer JR, Pisani P (1994) Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol 36:823–829PubMedCrossRefGoogle Scholar
  7. 7.
    Baulac S, Gourfinkel-An I, Nabbout R, Huberfeld G, Serratosa J, Leguern E, Baulac M (2004) Fever, genes, and epilepsy. Lancet Neurol 3:421–430PubMedCrossRefGoogle Scholar
  8. 8.
    Beers DR, Henkel JS, Schaefer DC, Rose JW, Stroop WG (1993) Neuropathology of herpes simplex virus encephalitis in a rat seizure model. J Neuropathol Exp Neurol 52:241–252PubMedCrossRefGoogle Scholar
  9. 9.
    Cagnin A, Myers R, Gunn RN, Lawrence AD, Stevens T, Kreutzberg GW, Jones T, Banati RB (2001) In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 124:2014–2027PubMedCrossRefGoogle Scholar
  10. 10.
    Chen SF, Huang CC, Wu HM, Chen SH, Liang YC, Hsu KS (2004) Seizure, neuron loss, and mossy fiber sprouting in herpes simplex virus type 1-infected organotypic hippocampal cultures. Epilepsia 45:322–332PubMedCrossRefGoogle Scholar
  11. 11.
    Chen YJ, Fang PC, Chow JC (2006) Clinical characteristics and prognostic factors of postencephalitic epilepsy in children. J Child Neurol 21:1047–1051PubMedCrossRefGoogle Scholar
  12. 12.
    Conrady CD, Drevets DA, Carr DJ (2010) Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing? J Neuroimmunol 220:1–9PubMedCrossRefGoogle Scholar
  13. 13.
    De Tiege X, De Laet C, Mazoin N, Christophe C, Mewasingh LD, Wetzburger C, Dan B (2005) Postinfectious immune-mediated encephalitis after pediatric herpes simplex encephalitis. Brain Dev 27:304–307PubMedCrossRefGoogle Scholar
  14. 14.
    De Tiege X, Rozenberg F, Burlot K, Gaudelus J, Ponsot G, Heron B (2006) Herpes simplex encephalitis: diagnostic problems and late relapse. Dev Med Child Neurol 48:60–63PubMedCrossRefGoogle Scholar
  15. 15.
    De Tiege X, Rozenberg F, Des Portes V, Lobut JB, Lebon P, Ponsot G, Heron B (2003) Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities. Neurology 61:241–243PubMedCrossRefGoogle Scholar
  16. 16.
    De Tiege X, Rozenberg F, Heron B (2008) The spectrum of herpes simplex encephalitis in children. Eur J Paediatr Neurol 12:72–81PubMedCrossRefGoogle Scholar
  17. 17.
    Donaire A, Carreno M, Agudo R, Delgado P, Bargallo N, Setoain X, Boget T, Raspall T, Falip M, Rumia J, Pintor L, Maestro I (2007) Presurgical evaluation in refractory epilepsy secondary to meningitis or encephalitis: bilateral memory deficits often preclude surgery. Epileptic Disord 9:127–133PubMedGoogle Scholar
  18. 18.
    Elbers JM, Bitnun A, Richardson SE, Ford-Jones EL, Tellier R, Wald RM, Petric M, Kolski H, Heurter H, MacGregor D (2007) A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics 119:e399–e407PubMedCrossRefGoogle Scholar
  19. 19.
    Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, Gumnit R, Zahn C, Westbrook E, Enos B (2003) Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 60:538–547PubMedCrossRefGoogle Scholar
  20. 20.
    Erba C, Visoná R, Zeroli C, Pravettoni G, Cocca G, Quirino T (2006) Herpes simplex encephalitis relapse: a case report. Case Rep Clin Pract Rev 7:27–29Google Scholar
  21. 21.
    Fabene PF, Bramanti P, Constantin G (2010) The emerging role for chemokines in epilepsy. J Neuroimmunol 224:22–27PubMedCrossRefGoogle Scholar
  22. 22.
    Fowler A, Stodberg T, Eriksson M, Wickstrom R (2010) Long-term outcomes of acute encephalitis in childhood. Pediatrics 126:e828–e835PubMedCrossRefGoogle Scholar
  23. 23.
    Free SL, Li LM, Fish DR, Shorvon SD, Stevens JM (1996) Bilateral hippocampal volume loss in patients with a history of encephalitis or meningitis. Epilepsia 37:400–405PubMedCrossRefGoogle Scholar
  24. 24.
    Friedman A, Dingledine R (2010) Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia 52(Suppl 3):33–39Google Scholar
  25. 25.
    Gilden DH, Mahalingam R, Cohrs RJ, Tyler KL (2007) Herpesvirus infections of the nervous system. Nat Clin Pract Neurol 3:82–94PubMedCrossRefGoogle Scholar
  26. 26.
    Gong T, Bingaman W, Danziger-Isakov L, Tuxhorn I, Goldfarb J (2010) Herpes simplex virus reactivation after subtotal hemispherectomy in a pediatric patient. Pediatr Infect Dis J 29:1148–1150PubMedCrossRefGoogle Scholar
  27. 27.
    Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS (2011) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835–844CrossRefGoogle Scholar
  28. 28.
    Hjalmarsson A, Blomqvist P, Skoldenberg B (2007) Herpes simplex encephalitis in Sweden, 1990–2001: incidence, morbidity, and mortality. Clin Infect Dis 45:875–880PubMedCrossRefGoogle Scholar
  29. 29.
    Höfler J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E (2011) Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia 52:148–152CrossRefGoogle Scholar
  30. 30.
    Holtkamp M, Othman J, Buchheim K, Meierkord H (2005) Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 76:534–539PubMedCrossRefGoogle Scholar
  31. 31.
    Hsieh WB, Chiu NC, Hu KC, Ho CS, Huang FY (2007) Outcome of herpes simplex encephalitis in children. J Microbiol Immunol Infect 40:34–38PubMedGoogle Scholar
  32. 32.
    Ichiyama T, Shoji H, Takahashi Y, Matsushige T, Kajimoto M, Inuzuka T, Furukawa S (2008) Cerebrospinal fluid levels of cytokines in non-herpetic acute limbic encephalitis: comparison with herpes simplex encephalitis. Cytokine 44:149–153PubMedCrossRefGoogle Scholar
  33. 33.
    Ito Y, Kimura H, Yabuta Y, Ando Y, Murakami T, Shiomi M, Morishima T (2000) Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis 30:185–187PubMedCrossRefGoogle Scholar
  34. 34.
    Joos AA, Ziyeh S, Rauer S, Keller E, Huzly D, Lucking CH (2003) Postinfectious autoimmune-mediated encephalitis eight months after herpes simplex encephalitis. Eur Neurol 50:54–56PubMedCrossRefGoogle Scholar
  35. 35.
    Kalita J, Nair PP, Misra UK (2008) Status epilepticus in encephalitis: a study of clinical findings, magnetic resonance imaging, and response to antiepileptic drugs. J Neurovirol 14:412–417PubMedCrossRefGoogle Scholar
  36. 36.
    Kamei S, Sekizawa T, Shiota H, Mizutani T, Itoyama Y, Takasu T, Morishima T, Hirayanagi K (2005) Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 76:1544–1549PubMedCrossRefGoogle Scholar
  37. 37.
    Kamei S, Taira N, Ishihara M, Sekizawa T, Morita A, Miki K, Shiota H, Kanno A, Suzuki Y, Mizutani T, Itoyama Y, Morishima T, Hirayanagi K (2009) Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis. Cytokine 46:187–193PubMedCrossRefGoogle Scholar
  38. 38.
    Kimura H, Aso K, Kuzushima K, Hanada N, Shibata M, Morishima T (1992) Relapse of herpes simplex encephalitis in children. Pediatrics 89:891–894PubMedGoogle Scholar
  39. 39.
    Kirkman NJ, Libbey JE, Wilcox KS, White HS, Fujinami RS (2010) Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia 51:454–464PubMedCrossRefGoogle Scholar
  40. 40.
    Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR, Hendricks RL (2008) Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322:268–271PubMedCrossRefGoogle Scholar
  41. 41.
    Kumar G, Kalita J, Misra UK (2009) Raised intracranial pressure in acute viral encephalitis. Clin Neurol Neurosurg 111:399–406PubMedCrossRefGoogle Scholar
  42. 42.
    Lahat E, Barr J, Barkai G, Paret G, Brand N, Barzilai A (1999) Long term neurological outcome of herpes encephalitis. Arch Dis Child 80:69–71PubMedCrossRefGoogle Scholar
  43. 43.
    Lancman ME, Morris HH 3rd (1996) Epilepsy after central nervous system infection: clinical characteristics and outcome after epilepsy surgery. Epilepsy Res 25:285–290PubMedCrossRefGoogle Scholar
  44. 44.
    Lee JH, Lee BI, Park SC, Kim WJ, Kim JY, Park SA, Huh K (1997) Experiences of epilepsy surgery in intractable seizures with past history of CNS infection. Yonsei Med J 38:73–78PubMedGoogle Scholar
  45. 45.
    Lee JH, Nam DH, Oh SY, Shin BS, Seo MW, Jeong SK, Lee JY (2012) Nonconvulsive Status Epilepticus Presenting as Epileptic Nystagmus in a Patient With Herpes Encephalitis. J Neuroophthalmol:in pressGoogle Scholar
  46. 46.
    Lee WT, Yu TW, Chang WC, Shau WY (2007) Risk factors for postencephalitic epilepsy in children: a hospital-based study in Taiwan. Eur J Paediatr Neurol 11:302–309PubMedCrossRefGoogle Scholar
  47. 47.
    Lellouch-Tubiana A, Fohlen M, Robain O, Rozenberg F (2000) Immunocytochemical characterization of long-term persistent immune activation in human brain after herpes simplex encephalitis. Neuropathol Appl Neurobiol 26:285–294PubMedCrossRefGoogle Scholar
  48. 48.
    Leung AK, Robson WL (2007) Febrile seizures. J Pediatr Health Care 21:250–255PubMedCrossRefGoogle Scholar
  49. 49.
    Lokensgard JR, Hu S, Sheng W, van Oijen M, Cox D, Cheeran MC, Peterson PK (2001) Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J Neurovirol 7:208–219PubMedCrossRefGoogle Scholar
  50. 50.
    Lundberg P, Ramakrishna C, Brown J, Tyszka JM, Hamamura M, Hinton DR, Kovats S, Nalcioglu O, Weinberg K, Openshaw H, Cantin EM (2008) The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol 82:7078–7088PubMedCrossRefGoogle Scholar
  51. 51.
    Maia R, Gouveia C, Moreira A, Casanova JL, Sancho-Shimizu V, Brito MJ (2011) Early "relapse" after herpetic encephalitis: extensive white matter lesions in an infant with interferon production deficit. J Child Neurol 26:369–372PubMedCrossRefGoogle Scholar
  52. 52.
    Mailles A, Stahl JP (2009) Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 49:1838–1847PubMedCrossRefGoogle Scholar
  53. 53.
    Malipiero U, Heuss C, Schlapbach R, Tschopp J, Gerber U, Fontana A (1999) Involvement of the N-methyl-d-aspartate receptor in neuronal cell death induced by cytotoxic T cell-derived secretory granules. Eur J Immunol 29:3053–3062PubMedCrossRefGoogle Scholar
  54. 54.
    Mandyla H, Anagnostakis D, Koutsovitis P, Siahanidou T, Youroukos S (2001) Late recurrence of herpes simplex virus meningoencephalitis in two infants. Eur J Pediatr 160:732–735PubMedGoogle Scholar
  55. 55.
    Marks DA, Kim J, Spencer DD, Spencer SS (1992) Characteristics of intractable seizures following meningitis and encephalitis. Neurology 42:1513–1518PubMedCrossRefGoogle Scholar
  56. 56.
    Marques CP, Cheeran MC, Palmquist JM, Hu S, Urban SL, Lokensgard JR (2008) Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol 181:6417–6426PubMedGoogle Scholar
  57. 57.
    Martinez-Torres F, Menon S, Pritsch M, Victor N, Jenetzky E, Jensen K, Schielke E, Schmutzhard E, de Gans J, Chung CH, Luntz S, Hacke W, Meyding-Lamade U (2008) Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. BMC Neurol 8:40PubMedCrossRefGoogle Scholar
  58. 58.
    Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF (2002) Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 59:205–210PubMedCrossRefGoogle Scholar
  59. 59.
    McGrath N, Anderson NE, Croxson MC, Powell KF (1997) Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 63:321–326PubMedCrossRefGoogle Scholar
  60. 60.
    Mekan SF, Wasay M, Khelaeni B, Saeed Z, Hassan A, Sheerani M (2005) Herpes simplex encephalitis: analysis of 68 cases from a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc 55:146–148PubMedGoogle Scholar
  61. 61.
    Misra UK, Kalita J (1998) Neurophysiological studies in herpes simplex encephalitis. Electromyogr Clin Neurophysiol 38:177–182PubMedGoogle Scholar
  62. 62.
    Misra UK, Kalita J (2009) Seizures in encephalitis: predictors and outcome. Seizure 18:583–587PubMedCrossRefGoogle Scholar
  63. 63.
    Misra UK, Kalita J, Nair PP (2008) Status epilepticus in central nervous system infections: an experience from a developing country. Am J Med 121:618–623PubMedCrossRefGoogle Scholar
  64. 64.
    Misra UK, Tan CT, Kalita J (2008) Viral encephalitis and epilepsy. Epilepsia 49(Suppl 6):13–18PubMedCrossRefGoogle Scholar
  65. 65.
    Nahmias AJ, Whitley RJ, Visintine AN, Takei Y, Alford CA Jr (1982) Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis 145:829–836PubMedCrossRefGoogle Scholar
  66. 66.
    O’Brien TJ, Moses H, Cambier D, Cascino GD (2002) Age of meningitis or encephalitis is independently predictive of outcome from anterior temporal lobectomy. Neurology 58:104–109PubMedCrossRefGoogle Scholar
  67. 67.
    Parmeggiani A, Riva R, Posar A, Rossi PG (1995) Possible interaction between acyclovir and antiepileptic treatment. Ther Drug Monit 17:312–315PubMedCrossRefGoogle Scholar
  68. 68.
    Perucca E, Tomson T (2011) The pharmacological treatment of epilepsy in adults. Lancet Neurol 10:446–456PubMedCrossRefGoogle Scholar
  69. 69.
    Radermecker J (1949) Aspects électroencephalographiques dans trois cas d′encéphalite subaigué. Acta Neurol Belg 49:222–232Google Scholar
  70. 70.
    Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29:142–160PubMedCrossRefGoogle Scholar
  71. 71.
    Reid AY, Galic MA, Teskey GC, Pittman QJ (2009) Febrile seizures: current views and investigations. Can J Neurol Sci 36:679–686PubMedGoogle Scholar
  72. 72.
    Rijkers K, Majoie HJ, Hoogland G, Kenis G, De Baets M, Vles JS (2009) The role of interleukin-1 in seizures and epilepsy: a critical review. Exp Neurol 216:258–271PubMedCrossRefGoogle Scholar
  73. 73.
    Rozenberg F, Deback C, Agut H (2011) Herpes simplex encephalitis: from virus to therapy. Infect Disord Drug Targets 11:235–250PubMedGoogle Scholar
  74. 74.
    Schlitt M, Bucher AP, Stroop WG, Pindak F, Bastian FO, Jennings RA, Lakeman AD, Whitley RJ (1988) Neurovirulence in an experimental focal herpes encephalitis: relationship to observed seizures. Brain Res 440:293–298PubMedCrossRefGoogle Scholar
  75. 75.
    Sellner J, Buonomano R, Nedeltchev K, Findling O, Schroth G, Surbek DV, Leib SL (2009) A case of maternal herpes simplex virus encephalitis during late pregnancy. Nat Clin Pract Neurol 5:51–56PubMedCrossRefGoogle Scholar
  76. 76.
    Sellner J, Dvorak F, Zhou Y, Haas J, Kehm R, Wildemann B, Meyding-Lamade U (2005) Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis. Neurosci Lett 374:197–202PubMedCrossRefGoogle Scholar
  77. 77.
    Sellner J, Simon F, Meyding-Lamade U, Leib SL (2006) Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation. Brain Res 1125:155–162PubMedCrossRefGoogle Scholar
  78. 78.
    Sergerie Y, Rivest S, Boivin G (2007) Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis. J Infect Dis 196:853–860PubMedCrossRefGoogle Scholar
  79. 79.
    Shimeld C, Efstathiou S, Hill T (2001) Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infection. J Virol 75:5252–5262PubMedCrossRefGoogle Scholar
  80. 80.
    Shorvon S (2010) Handbook of Epilepsy Treatment. Wiley-Blackwell, OxfordCrossRefGoogle Scholar
  81. 81.
    Shorvon S, Baulac M, Cross H, Trinka E, Walker M (2008) The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia 49:1277–1285PubMedCrossRefGoogle Scholar
  82. 82.
    Skoldenberg B, Aurelius E, Hjalmarsson A, Sabri F, Forsgren M, Andersson B, Linde A, Strannegard O, Studahl M, Hagberg L, Rosengren L (2006) Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol 253:163–170PubMedCrossRefGoogle Scholar
  83. 83.
    Smith JB, Westmoreland BF, Reagan TJ, Sandok BA (1975) A distinctive clinical EEG profile in herpes simplex encephalitis. Mayo Clin Proc 50:469–474PubMedGoogle Scholar
  84. 84.
    Smith MG, Lennette EH, Reames HR (1941) Isolation of the virus of herpes simplex and the demonstration of intranuclear inclusions in a case of acute encephalitis. Am J Pathol 17(55–68):51Google Scholar
  85. 85.
    Solbrig MV, Adrian R, Chang DY, Perng GC (2006) Viral risk factor for seizures: pathobiology of dynorphin in herpes simplex viral (HSV-1) seizures in an animal model. Neurobiol Dis 23:612–620PubMedCrossRefGoogle Scholar
  86. 86.
    Solomon T, Hart IJ, Beeching NJ (2007) Viral encephalitis: a clinician’s guide. Pract Neurol 7:288–305PubMedCrossRefGoogle Scholar
  87. 87.
    Spiegel R, Miron D, Yodko H, Lumelsky D, Habib A, Horovitz Y (2008) Late relapse of herpes simplex virus encephalitis in a child due to reactivation of latent virus: clinicopathological report and review. J Child Neurol 23:344–348PubMedCrossRefGoogle Scholar
  88. 88.
    Stahl JP, Mailles A, De Broucker T (2011) Herpes simplex encephalitis and management of acyclovir in encephalitis patients in France. Epidemiol Infect:1-10Google Scholar
  89. 89.
    Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, Kennedy PG (2010) Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 17:999-e957CrossRefGoogle Scholar
  90. 90.
    Studahl M, Sköldenberg B (2006) Herpes simplex encephalitis and other neurological syndromes caused by herpes simplex virus-1. In: Studahl M, Cinque P, Bergström T (eds) Herpes simplex viruses. Taylor & Francis, New York, pp 275–316Google Scholar
  91. 91.
    Trinka E (2004) Presurgical evaluation in patients with inflammatory lesions: meningitis, encephalitis, and Rasmussen's syndrome. In: Rosenow F, Lüders HO (eds) Handbook of Clinical Neurophysiology. Elsevier, Amsterdam, pp 423–440Google Scholar
  92. 92.
    Trinka E (2011) What is the evidence to use new intravenous AEDs in status epilepticus? Epilepsia 52:35–38PubMedCrossRefGoogle Scholar
  93. 93.
    Trinka E (2009) What is the relative value of the standard anticonvulsants: phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam? Epilepsia 50(Suppl 12):40–43PubMedCrossRefGoogle Scholar
  94. 94.
    Trinka E, Dubeau F, Andermann F, Bastos A, Hui A, Li LM, Kohler S, Olivier A (2000) Clinical findings, imaging characteristics and outcome in catastrophic post-encephalitic epilepsy. Epileptic Disord 2:153–162PubMedGoogle Scholar
  95. 95.
    Trinka E, Dubeau F, Andermann F, Hui A, Bastos A, Li LM, Kohler S, Olivier A (2000) Successful epilepsy surgery in catastrophic postencephalitic epilepsy. Neurology 54:2170–2173PubMedCrossRefGoogle Scholar
  96. 96.
    Tyler KL (2004) Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret’s. Herpes 11(Suppl 2):57A–64APubMedGoogle Scholar
  97. 97.
    Valencia I, Miles DK, Melvin J, Khurana D, Kothare S, Hardison H, Legido A (2004) Relapse of herpes encephalitis after acyclovir therapy: report of two new cases and review of the literature. Neuropediatrics 35:371–376PubMedCrossRefGoogle Scholar
  98. 98.
    van Jaarsveld MF, Walubo A, du Plessis JB (2007) Interaction between valproic acid and acyclovir after intravenous and oral administration in a rabbit model. Basic Clin Pharmacol Toxicol 101:434–440PubMedCrossRefGoogle Scholar
  99. 99.
    Vezzani A, Aronica E, Mazarati A, Pittman QJ (2011) Epilepsy and brain inflammation. Exp Neurol (in press). PMID:21985866Google Scholar
  100. 100.
    Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, De Simoni MG, Sperk G, Andell-Jonsson S, Lundkvist J, Iverfeldt K, Bartfai T (2000) Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 97:11534–11539PubMedCrossRefGoogle Scholar
  101. 101.
    Wasay M, Mekan SF, Khelaeni B, Saeed Z, Hassan A, Cheema Z, Bakshi R (2005) Extra temporal involvement in herpes simplex encephalitis. Eur J Neurol 12:475–479PubMedCrossRefGoogle Scholar
  102. 102.
    Whitley RJ (2006) Herpes simplex encephalitis: adolescents and adults. Antiviral Res 71:141–148PubMedCrossRefGoogle Scholar
  103. 103.
    Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, Hanley D, Nahmias AJ, Soong SJ (1986) Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 314:144–149PubMedCrossRefGoogle Scholar
  104. 104.
    Whitley RJ, Soong SJ, Linneman C Jr, Liu C, Pazin G, Alford CA (1982) Herpes simplex encephalitis. Clinical Assessment. JAMA 247:317–320PubMedCrossRefGoogle Scholar
  105. 105.
    Wu HM, Huang CC, Chen SH, Liang YC, Tsai JJ, Hsieh CL, Hsu KS (2003) Herpes simplex virus type 1 inoculation enhances hippocampal excitability and seizure susceptibility in mice. Eur J Neurosci 18:3294–3304PubMedCrossRefGoogle Scholar
  106. 106.
    Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296:964–973PubMedCrossRefGoogle Scholar
  107. 107.
    Yoshioka M, Kuroki S, Mizue H (1989) Clinical and electroencephalographic studies of postencephalitic epilepsy. Acta Paediatr Jpn 31:480–483PubMedCrossRefGoogle Scholar
  108. 108.
    Zattoni M, Mura ML, Deprez F, Schwendener RA, Engelhardt B, Frei K, Fritschy JM (2011) Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci 31:4037–4050PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.Department of Neurology, Christian-Doppler-KlinikParacelsus Medical UniversitySalzburgAustria
  2. 2.Department of Neurology, Klinikum rechts der IsarTechnische Universität MünchenMunichGermany
  3. 3.2nd Neurological DepartmentKrankenhaus Hietzing mit Neurologischem Zentrum RosenhügelViennaAustria

Personalised recommendations